Pharmacy Practice and Science Department Highlights: August 2022

Sept. 1, 2022
A pharmacist speaking with a patient during a health fair.

(August 1, 2022) 

Publications

A systematic review of clinical outcomes from pharmacist provided medication therapy management (MTM) among patients with diabetes, hypertension, or dyslipidemia. Healthcare. 2022;10(7):1207. Doi: 10.3390/healthcare10071207.

  • Marupuru S.
  • Roether A.
  • Guimond AJ.
  • Stanley C.
  • Pesqueira T.
  • Axon DR.

Value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis. Journal of Medical Economics 2022;25:894-902.

  • Obeng-Kusi M.

A proposed personalized spine care protocol (SpineScreen) to treat visualized pain generators: an illustrative study comparing clinical outcomes and postoperative reoperations between targeted endoscopic lumbar decompression surgery, minimally invasive TLIF and open laminectomy. Journal of Personalized Medicine 2022;12:1065.

  • Lewandrowski KU.
  • Abraham I.
  • León JFR.
  • Telfeian AE.
  • Lorio MP.
  • Hellinger S.
  • Knight M.
  • De Carvalho PST.
  • Ramos MRF.
  • Dowling Á.
  • Rodriguez Garcia M.
  • Muhammad F.
  • Hussain N.
  • Yamamoto V.
  • Babak K.
  • Yeung A.
     

Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 study): multicenter real-world evidence. Expert Review of Anti-Infective Therapy 2022;20:1037-1047.

  • Mohzari YA,
  • Alamer A,
  • Alattas M,
  • Alrashed AA,
  • Alshehab NA
  • Alkhaldi TK
  • Alamer AA
  • Asdaq SMB
  • Aljefri D
  • Alajami HN
  • Alsowaida YS
  • Mathew M
  • AlMusawa MI
  • Alomar M
  • Alharbi RY
  • Khuwaja M
  • Bamogaddam RF
  • Alharthi AH
  • Faqihi AY
  • Alrumayyan BF
  • Alshareef A.
  • Alhassan BM.
  • Damfu NY.
  • Alajmi GS.
  • Albujaidy A.
  • Alghalbi M.
  • Alajlan SA.
  • Abraham I.
  • Almulhim AS.

To try or not to try, that’s not the question: phase 3 trials of biosimilars and beyond. Center for Biosimilars 2022. (monthly column)

Decision curve analysis and the net benefit of novel tests. JAMA Dermatology 2022;158:684.

The enemy of your enemy should be your friend: why biosimilar companies should collaborate. Center for Biosimilars 2022. (monthly column)

Student pharmacists’ perceptions of their professional identity. Curr Pharm Teach Learn. 2022; 14(6):712-719.

Presentations

Cooley J, Larson, S, Cheung M. presented "Put on your game face: An interactive board game to review precepting fundamentals" at the American Society of Health-System Pharmacists Summer Meeting, June 14, 2022, Phoenix and at the Arizona Pharmacy Association Annual Meeting, June 17, 2022, Phoenix.

Kudos

Jason Karnes received grant R01 HL156993 from NIH/National Heart, Lung, and Blood Institute for ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia The goals of this work are to determine the role of ABO variation in heparin-induced thrombocytopenia, determine the influence of genomic variation on platelet factor 4/heparin antibody production, and to identify intrinsic immune cell involvement in HIT using a single cell-RNA-TCR-CITE-seq approach

Jeannie K. Lee received a grant from NIH/National Institute of Nursing Research for Digital Technology to Support Adherence to Hypertension Medications for Older Adults with Mild Cognitive Impairment. The goal is to modify our existing MEDSReM application (App) to make it more readily usable and appropriate for individuals with memory difficulties by automating input of medication information and delivering reminders through wearable technology.

Travis Wheeler received an R21 grant and an R01 grant for his work.